Is Onconetix Inc (NASDAQ: ONCO) Still A Buy After A -28.75% Weekly Drop?

During the last session, Onconetix Inc (NASDAQ:ONCO)’s traded shares were 0.97 million, with the beta value of the company hitting 3.19. At the end of the trading day, the stock’s price was $0.23, reflecting an intraday gain of 1.33% or $0.01. The 52-week high for the ONCO share is $21.40, that puts it down -9204.35 from that peak though still a striking 8.7% gain since the share price plummeted to a 52-week low of $0.21. The company’s market capitalization is $3.31M, and the average trade volume was 9.33 million shares over the past three months.

Onconetix Inc (NASDAQ:ONCO) trade information

Onconetix Inc (ONCO) registered a 1.33% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.33% in intraday trading to $0.23, hitting a weekly high. The stock’s 5-day price performance is -28.75%, and it has moved by -62.56% in 30 days. Based on these gigs, the overall price performance for the year is -96.91%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -116.38%.

ONCO Dividends

Onconetix Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of Onconetix Inc (ONCO) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that Fidelity Extended Market Index Fund owns about 53.6 shares. This amounts to just over 0.37 percent of the company’s overall shares, with a $12219.0 market value. The same data shows that the other fund manager holds slightly less at 1.84, or about 0.01% of the stock, which is worth about $418.0.